ABSTRACT
Body condition score (BCS) at calving is a vital indicator of the effectiveness of the beginning of lactation in dairy animals. The purpose of this study was to examine the effect of BCS at calving on milk production and transition success in dairy buffaloes. Thirty-six (36) Nili Ravi buffaloes were enrolled at 40 days of expected calving and followed through 90 days of lactation. The buffaloes were categorized into three groups according to their BCS (on a scale of 1-5 with 0.25 increments) as follows: 1) low, buffaloes with BCS ≤ 3.0; 2) medium, buffaloes with BCS 3.25-3.5; and 3) high, buffaloes with BCS ≥ 3.75. All buffaloes were fed a similar diet ad libitum. The lactation diet had increased concentrate allowance according to milk yield. The results revealed that the BCS at calving did not affect milk yield; however, fat percentage (fat%) was lower in the low-BCS group. Dry matter intake (DMI) was similar among the treatment groups, although post-calving BCS loss was greater in the high-BCS group compared to the medium- and the low-BCS groups. Similarly, the buffaloes in the high-BCS group had higher non-esterified fatty acids (NEFA) concentration compared to the low- and medium-BCS groups. No cases of metabolic disorders were observed during the study. The present results suggest that the buffaloes in the medium-BCS group appeared to perform better compared to the low- and the high-BCS groups with respect to milk fat% and blood NEFA concentration.
ABSTRACT
PURPOSE: The aim of the study was to determine the efficacy of whole body vibration (WBV) therapy on pain, neuropathy disability score, balance, proprioception and quality of life (QOL) in patients with painful diabetic peripheral neuropathy (PDPN). METHODS: Twenty-six (16 males and 10 females) patients with PDPN were selected on the basis of inclusion and exclusion criteria. Subjects were randomly allocated to an experimental group (n = 13, age = 60.69 ± 5.08) and a control group (n = 13, age = 59.54 ± 4.25). The experimental group was given WBV therapy for six weeks (3 days/week) in addition to standard medical care, dietary advice and lifestyle modifications. Control group was provided only standard medical care, dietary advice and lifestyle modifications. Outcome measures included numeric pain rating scale (NPRS), Leeds assessment of neuropathic symptoms and signs (LANSS), vibration perception threshold (VPT), neuropathy disability score (NDS), proprioception, single-leg stance test (SLST), timed up and go test (TUGT) and short form 36 questionnaire (SF-36). RESULTS: NPRS, LANSS, NDS, SLST and TUGT showed significant time effect (p ≤ 0.022) and time×group interaction (p ≤ 0.007), whereas group effect was found to be significant only in LANSS (p = 0.001). VPT showed significant group effect (p ≤ 0.045) and time×group interaction (p ≤ 0.007) at great toe, metatarsal head and total average score. SF-36 was found to be significant time effect (p ≤ 0.024) in all domains except limitations due to physical health (p = 0.461). SF-36 average score was found be significant for group effect (p = 0.002) and time×group interaction (p < 0.001). CONCLUSION: WBV improves sensory sensations like pain and vibration perception, neuropathy disability score, balance measures and health-related QOL in PDPN.
